Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Prednisone/tozinameran/vinblastine

Relapse of Evans syndrome and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cvetkovic M, et al. Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review. Journal of Infection in Developing Countries 17 : 800-804, No. 6, Jun 2023. Available from: URL: http://doi.org/10.3855/jidc.17719 Cvetkovic M, et al. Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review. Journal of Infection in Developing Countries 17 : 800-804, No. 6, Jun 2023. Available from: URL: http://​doi.​org/​10.​3855/​jidc.​17719
Metadaten
Titel
Prednisone/tozinameran/vinblastine
Relapse of Evans syndrome and lack of efficacy: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45976-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drug

Case report

BBIBP-CorV

Case report

Multiple drugs